PUBLISHER: Polaris Market Research | PRODUCT CODE: 1762408
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1762408
Asia Pacific Immunohistochemistry Market Size, Share, Trends, Industry Analysis Report: By Product (Antibodies, Reagents, Equipment, and Kits), By Application, By End Use, and By Country - Market Forecast, 2025-2034
The Asia Pacific Immunohistochemistry market size is expected to reach USD 1,218.85 million by 2034, according to a new study by Polaris Market Research. The report "Asia Pacific Immunohistochemistry Market Size, Share, Trends, Industry Analysis Report: By Product (Antibodies, Reagents, Equipment, and Kits), By Application, By End Use, and By Country - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Immunohistochemistry (IHC) is a critical technique used in pathology and research to detect specific antigens in tissue samples, aiding in disease diagnosis and treatment planning. The Asia Pacific immunohistochemistry (IHC) market is experiencing significant growth, driven by the increasing prevalence of chronic diseases such as cancer, rising demand for personalized medicine, and advancements in diagnostic technologies. Countries such as China, Japan, and India are driving the market due to expanding healthcare infrastructure, growing investments in biotechnology, and increasing awareness of early disease detection. The market is also benefiting from the adoption of automated IHC systems and the development of novel biomarkers.
The increasing prevalence of cancer and other chronic diseases in Asia Pacific is a major driver for the Asia Pacific immunohistochemistry market expansion. There is a growing need for accurate diagnostic tools to detect and classify tumors, with cancer cases on the rise. Immunohistochemistry plays a crucial role in cancer diagnosis by identifying tumor-specific biomarkers, enabling targeted therapies. Governments and healthcare organizations are focusing on improving cancer screening programs, further boosting the demand for immunohistochemistry (IHC) techniques.
Asia Pacific Immunohistochemistry Market Report Highlights
In terms of product, the antibodies segment dominated the Asia Pacific immunohistochemistry market share in 2024 due to their critical role in diagnostic and research applications. Researchers and clinicians across relied heavily on antibodies for the detection and analysis of specific cellular proteins.
The kits segment is expected to grow at a rapid pace in the coming years, owing to its growing adoption in diagnostic laboratories and research institutions.
Based on end use, the hospitals and diagnostic laboratories segment accounted for a major market share in 2024 due to increasing demand for accurate and early disease diagnosis.
In the market, China accounted for a major market share in 2024 due to a rapidly expanding healthcare system, substantial government investments in cancer research, and a growing aging population susceptible to chronic illnesses.
The market in India is projected to grow at a rapid pace in the coming years, owing to the expanding population, coupled with a rising cancer burden and increasing awareness of early diagnosis.
A few of the key market players are Abcam plc.; Agilent Technologies, Inc.; Amos Scientific PTY. LTD.; Bio SB; Bio-Rad Laboratories, Inc.; Cell Signaling Technology, Inc.; Danaher Corporation; HiMedia Laboratories; IMGENEX INDIA Pvt. Ltd.; Immuno-Biological Laboratories Co, Ltd.; Kyowa Kirin Co., Ltd.; Merck KGaA; PathnSitu Biotechnologies Pvt Ltd; PerkinElmer, Inc.; Roche Ltd.; Sino Biological, Inc.; and Thermo Fisher Scientific Inc.
Polaris Market Research has segmented the Asia Pacific immunohistochemistry market report on the basis of product, application, end use, and country:
By Product Outlook (Revenue, USD Million, 2020-2034)
Antibodies
Primary Antibodies
Secondary Antibodies
Reagents
Histological Stains
Blocking Sera and Reagents
Chromogenic Substrates
Fixation Reagents
Organic Solvents
Proteolytic Enzymes
Diluents
Other Reagents
Equipment
Slide Staining Systems
Tissue Microarrays
Tissue Processing Systems
Slide Scanners
Others
Kits
By Application Outlook (Revenue, USD Million, 2020-2034)
Diagnostics
Cancer
Infectious Diseases
Cardiovascular Diseases
Autoimmune Diseases
Diabetes Mellitus
Nephrological Diseases
Others
Research
By End Use Outlook (Revenue, USD Million, 2020-2034)
Hospitals and Diagnostic Laboratories
Research Institutes
Others
By Country Outlook (Revenue, USD Million, 2020-2034)
China
Japan
India
Australia
Rest of APAC
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Asia Pacific Immunohistochemistry Market Insights
- 4.1. Asia Pacific Immunohistochemistry Market - Market Snapshot
- 4.2. Asia Pacific Immunohistochemistry Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Geriatric Population
- 4.2.1.2. Increasing Product Development and Launches
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Cost of Immunohistochemistry
- 4.2.3. Public opinion and privacy legal precedents
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Asia Pacific Immunohistochemistry Market Trends
- 4.6. Value Chain Analysis
5. Asia Pacific Immunohistochemistry Market, by Product
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Asia Pacific Immunohistochemistry Market, by Product, 2020-2034 (USD Million)
- 5.3. Antibodies
- 5.3.1. Asia Pacific Immunohistochemistry Market, by Antibodies, by Region, 2020-2034 (USD Million)
- 5.3.2. Primary Antibodies
- 5.3.2.1. Asia Pacific Immunohistochemistry Market, by Primary Antibodies, by Region, 2020-2034 (USD Million)
- 5.3.3. Secondary Antibodies
- 5.3.3.1. Asia Pacific Immunohistochemistry Market, by Secondary Antibodies, by Region, 2020-2034 (USD Million)
- 5.4. Reagents
- 5.4.1. Asia Pacific Immunohistochemistry Market, by Reagents, by Region, 2020-2034 (USD Million)
- 5.4.2. Histological Stains
- 5.4.2.1. Asia Pacific Immunohistochemistry Market, by Histological Stains, by Region, 2020-2034 (USD Million)
- 5.4.3. Blocking Sera and Reagents
- 5.4.3.1. Asia Pacific Immunohistochemistry Market, by Blocking Sera and Reagents, by Region, 2020-2034 (USD Million)
- 5.4.4. Chromogenic Substrates
- 5.4.4.1. Asia Pacific Immunohistochemistry Market, by Chromogenic Substrates, by Region, 2020-2034 (USD Million)
- 5.4.5. Fixation Reagents
- 5.4.5.1. Asia Pacific Immunohistochemistry Market, by Fixation Reagents, by Region, 2020-2034 (USD Million)
- 5.4.6. Organic Solvents
- 5.4.6.1. Asia Pacific Immunohistochemistry Market, by Organic Solvents, by Region, 2020-2034 (USD Million)
- 5.4.7. Proteolytic Enzymes
- 5.4.7.1. Asia Pacific Immunohistochemistry Market, by Proteolytic Enzymes, by Region, 2020-2034 (USD Million)
- 5.4.8. Diluents
- 5.4.8.1. Asia Pacific Immunohistochemistry Market, by Diluents, by Region, 2020-2034 (USD Million)
- 5.4.9. Others Reagents
- 5.4.9.1. Asia Pacific Immunohistochemistry Market, by Other Reagents, by Region, 2020-2034 (USD Million)
- 5.5. Equipment
- 5.5.1. Asia Pacific Immunohistochemistry Market, by Equipment, by Region, 2020-2034 (USD Million)
- 5.5.2. Slide Staining Systems
- 5.5.2.1. Asia Pacific Immunohistochemistry Market, by Slide Staining Systems, by Region, 2020-2034 (USD Million)
- 5.5.3. Tissue Microarrays
- 5.5.3.1. Asia Pacific Immunohistochemistry Market, by Tissue Microarrays, by Region, 2020-2034 (USD Million)
- 5.5.4. Tissue Processing Systems
- 5.5.4.1. Asia Pacific Immunohistochemistry Market, by Tissue Processing Systems, by Region, 2020-2034 (USD Million)
- 5.5.5. Slide Scanners
- 5.5.5.1. Asia Pacific Immunohistochemistry Market, by Slide Scanners, by Region, 2020-2034 (USD Million)
- 5.5.6. Others
- 5.5.6.1. Asia Pacific Immunohistochemistry Market, by Others, by Region, 2020-2034 (USD Million)
- 5.6. Kites
- 5.6.1. Asia Pacific Immunohistochemistry Market, by Kites, by Region, 2020-2034 (USD Million)
6. Asia Pacific Immunohistochemistry Market, by Application
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Asia Pacific Immunohistochemistry Market, by Application, 2020-2034 (USD Million)
- 6.3. Diagnostic
- 6.3.1. Asia Pacific Immunohistochemistry Market, by Diagnostic, by Region, 2020-2034 (USD Million)
- 6.3.2. Cancer
- 6.3.2.1. Asia Pacific Immunohistochemistry Market, by Cancer, by Region, 2020-2034 (USD Million)
- 6.3.3. Infectious Diseases
- 6.3.3.1. Asia Pacific Immunohistochemistry Market, by Diagnostic, by Region, 2020-2034 (USD Million)
- 6.3.4. Cardiovascular Diseases
- 6.3.4.1. Asia Pacific Immunohistochemistry Market, by Cardiovascular Diseases, by Region, 2020-2034 (USD Million)
- 6.3.5. Autoimmune Diseases
- 6.3.5.1. Asia Pacific Immunohistochemistry Market, by Autoimmune Diseases, by Region, 2020-2034 (USD Million)
- 6.3.6. Diabetes Mellitus
- 6.3.6.1. Asia Pacific Immunohistochemistry Market, by Diabetes Mellitus, by Region, 2020-2034 (USD Million)
- 6.3.7. Nephrological Diseases
- 6.3.7.1. Asia Pacific Immunohistochemistry Market, by Nephrological Diseases, by Region, 2020-2034 (USD Million)
- 6.3.8. Others
- 6.3.8.1. Asia Pacific Immunohistochemistry Market, by Others, by Region, 2020-2034 (USD Million)
- 6.4. Research
- 6.4.1. Asia Pacific Immunohistochemistry Market, by Research, by Region, 2020-2034 (USD Million)
7. Asia Pacific Immunohistochemistry Market, by End Use
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Asia Pacific Immunohistochemistry Market, by End Use, 2020-2034 (USD Million)
- 7.3. Hospitals and Diagnostic Laboratories
- 7.3.1. Asia Pacific Immunohistochemistry Market, by Hospitals and Diagnostic Laboratories, by Region, 2020-2034 (USD Million)
- 7.4. Research Institutes
- 7.4.1. Asia Pacific Immunohistochemistry Market, by Research Institutes, by Region, 2020-2034 (USD Million)
- 7.5. Others
- 7.5.1. Asia Pacific Immunohistochemistry Market, by Others, by Region, 2020-2034 (USD Million)
8. Asia Pacific Immunohistochemistry Market, by Geography
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Asia Pacific Immunohistochemistry Market Assessment, By Geography, 2020-2034 (USD Million)
- 8.3. Asia Pacific Immunohistochemistry Market - Asia Pacific
- 8.3.1. Asia Pacific: Asia Pacific Immunohistochemistry Market, by Product, 2020-2034 (USD Million)
- 8.3.2. Asia Pacific: Asia Pacific Immunohistochemistry Market, by Application, 2020-2034 (USD Million)
- 8.3.3. Asia Pacific: Asia Pacific Immunohistochemistry Market, by End Use, 2020-2034 (USD Million)
- 8.3.4. Asia Pacific Immunohistochemistry Market - China
- 8.3.4.1. China: Asia Pacific Immunohistochemistry Market, by Product, 2020-2034 (USD Million)
- 8.3.4.2. China: Asia Pacific Immunohistochemistry Market, by Application, 2020-2034 (USD Million)
- 8.3.4.3. China: Asia Pacific Immunohistochemistry Market, by End Use, 2020-2034 (USD Million)
- 8.3.5. Asia Pacific Immunohistochemistry Market - India
- 8.3.5.1. India: Asia Pacific Immunohistochemistry Market, by Product, 2020-2034 (USD Million)
- 8.3.5.2. India: Asia Pacific Immunohistochemistry Market, by Application, 2020-2034 (USD Million)
- 8.3.5.3. India: Asia Pacific Immunohistochemistry Market, by End Use, 2020-2034 (USD Million)
- 8.3.6. Asia Pacific Immunohistochemistry Market - Malaysia
- 8.3.6.1. Malaysia: Asia Pacific Immunohistochemistry Market, by Product, 2020-2034 (USD Million)
- 8.3.6.2. Malaysia: Asia Pacific Immunohistochemistry Market, by Application, 2020-2034 (USD Million)
- 8.3.6.3. Malaysia: Asia Pacific Immunohistochemistry Market, by End Use, 2020-2034 (USD Million)
- 8.3.7. Asia Pacific Immunohistochemistry Market - Japan
- 8.3.7.1. Japan: Asia Pacific Immunohistochemistry Market, by Product, 2020-2034 (USD Million)
- 8.3.7.2. Japan: Asia Pacific Immunohistochemistry Market, by Application, 2020-2034 (USD Million)
- 8.3.7.3. Japan: Asia Pacific Immunohistochemistry Market, by End Use, 2020-2034 (USD Million)
- 8.3.8. Asia Pacific Immunohistochemistry Market - Indonesia
- 8.3.8.1. Indonesia: Asia Pacific Immunohistochemistry Market, by Product, 2020-2034 (USD Million)
- 8.3.8.2. Indonesia: Asia Pacific Immunohistochemistry Market, by Application, 2020-2034 (USD Million)
- 8.3.8.3. Indonesia: Asia Pacific Immunohistochemistry Market, by End Use, 2020-2034 (USD Million)
- 8.3.9. Asia Pacific Immunohistochemistry Market - South Korea
- 8.3.9.1. South Korea: Asia Pacific Immunohistochemistry Market, by Product, 2020-2034 (USD Million)
- 8.3.9.2. South Korea: Asia Pacific Immunohistochemistry Market, by Application, 2020-2034 (USD Million)
- 8.3.9.3. South Korea: Asia Pacific Immunohistochemistry Market, by End Use, 2020-2034 (USD Million)
- 8.3.10. Asia Pacific Immunohistochemistry Market - Australia
- 8.3.10.1. Australia: Asia Pacific Immunohistochemistry Market, by Product, 2020-2034 (USD Million)
- 8.3.10.2. Australia: Asia Pacific Immunohistochemistry Market, by Application, 2020-2034 (USD Million)
- 8.3.10.3. Australia: Asia Pacific Immunohistochemistry Market, by End Use, 2020-2034 (USD Million)
- 8.3.11. Asia Pacific Immunohistochemistry Market - Rest of Asia Pacific
- 8.3.11.1. Rest of Asia Pacific: Asia Pacific Immunohistochemistry Market, by Product, 2020-2034 (USD Million)
- 8.3.11.2. Rest of Asia Pacific: Asia Pacific Immunohistochemistry Market, by Application, 2020-2034 (USD Million)
- 8.3.11.3. Rest of Asia Pacific: Asia Pacific Immunohistochemistry Market, by End Use, 2020-2034 (USD Million)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Abcam plc.
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Agilent Technologies, Inc.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Amos Scientific PTY. LTD.
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Bio SB
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Bio-Rad Laboratories, Inc
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Cell Signaling Technology, Inc.
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Danaher Corporation
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. HiMedia Laboratories
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. IMGENEX INDIA Pvt. Ltd.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Immuno-Biological Laboratories Co, Ltd.
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Kyowa Kirin Co., Ltd.
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Merck KGaA
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
- 10.13. PathnSitu Biotechnologies Pvt Ltd
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
- 10.14. PerkinElmer, Inc.
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
- 10.15. Roche Ltd.
- 10.15.1. Company Overview
- 10.15.2. Financial Performance
- 10.15.3. Product Benchmarking
- 10.15.4. Recent Development
- 10.16. Sino Biological, Inc.
- 10.16.1. Company Overview
- 10.16.2. Financial Performance
- 10.16.3. Product Benchmarking
- 10.16.4. Recent Development
- 10.17. Thermo Fisher Scientific Inc.
- 10.17.1. Company Overview
- 10.17.2. Financial Performance
- 10.17.3. Product Benchmarking
- 10.17.4. Recent Development
List of Tables:
- Table 1 Asia Pacific Immunohistochemistry Market, by Product, 2020-2034 (USD Million)
- Table 2 Asia Pacific Immunohistochemistry Market, by Application, 2020-2034 (USD Million)
- Table 3 Asia Pacific Immunohistochemistry Market, by End Use, 2020-2034 (USD Million)
- Table 4 Asia Pacific: Asia Pacific Immunohistochemistry Market, by Product, 2020-2034 (USD Million)
- Table 5 Asia Pacific: Asia Pacific Immunohistochemistry Market, by Application, 2020-2034 (USD Million)
- Table 6 Asia Pacific: Asia Pacific Immunohistochemistry Market, by End Use, 2020-2034 (USD Million)
- Table 7 China: Asia Pacific Immunohistochemistry Market, by Product, 2020-2034 (USD Million)
- Table 8 China: Asia Pacific Immunohistochemistry Market, by Application, 2020-2034 (USD Million)
- Table 9 China: Asia Pacific Immunohistochemistry Market, by End Use, 2020-2034 (USD Million)
- Table 10 India: Asia Pacific Immunohistochemistry Market, by Product, 2020-2034 (USD Million)
- Table 11 India: Asia Pacific Immunohistochemistry Market, by Application, 2020-2034 (USD Million)
- Table 12 India: Asia Pacific Immunohistochemistry Market, by End Use, 2020-2034 (USD Million)
- Table 13 Malaysia: Asia Pacific Immunohistochemistry Market, by Product, 2020-2034 (USD Million)
- Table 14 Malaysia: Asia Pacific Immunohistochemistry Market, by Application, 2020-2034 (USD Million)
- Table 15 Malaysia: Asia Pacific Immunohistochemistry Market, by End Use, 2020-2034 (USD Million)
- Table 16 Japan: Asia Pacific Immunohistochemistry Market, by Product, 2020-2034 (USD Million)
- Table 17 Japan: Asia Pacific Immunohistochemistry Market, by Application, 2020-2034 (USD Million)
- Table 18 Japan: Asia Pacific Immunohistochemistry Market, by End Use, 2020-2034 (USD Million)
- Table 19 Indonesia: Asia Pacific Immunohistochemistry Market, by Product, 2020-2034 (USD Million)
- Table 20 Indonesia: Asia Pacific Immunohistochemistry Market, by Application, 2020-2034 (USD Million)
- Table 21 Indonesia: Asia Pacific Immunohistochemistry Market, by End Use, 2020-2034 (USD Million)
- Table 22 South Korea: Asia Pacific Immunohistochemistry Market, by Product, 2020-2034 (USD Million)
- Table 23 South Korea: Asia Pacific Immunohistochemistry Market, by Application, 2020-2034 (USD Million)
- Table 24 South Korea: Asia Pacific Immunohistochemistry Market, by End Use, 2020-2034 (USD Million)
- Table 25 Australia: Asia Pacific Immunohistochemistry Market, by Product, 2020-2034 (USD Million)
- Table 26 Australia: Asia Pacific Immunohistochemistry Market, by Application, 2020-2034 (USD Million)
- Table 27 Australia: Asia Pacific Immunohistochemistry Market, by End Use, 2020-2034 (USD Million)
- Table 28 Rest of Asia Pacific: Asia Pacific Immunohistochemistry Market, by Product, 2020-2034 (USD Million)
- Table 29 Rest of Asia Pacific: Asia Pacific Immunohistochemistry Market, by Application, 2020-2034 (USD Million)
- Table 30 Rest of Asia Pacific: Asia Pacific Immunohistochemistry Market, by End Use, 2020-2034 (USD Million)
List of Figures:
- Figure 1. Asia Pacific Immunohistochemistry Market, 2020-2034 (USD Million)
- Figure 2. Integrated Ecosystem
- Figure 3. Research Methodology: Top-Down & Bottom-Up Price
- Figure 4. Market by Geography
- Figure 5. Porter's Five Forces
- Figure 6. Market by Product
- Figure 7. Asia Pacific Immunohistochemistry Market, by Product, 2024 & 2034 (USD Million)
- Figure 8. Market by Application
- Figure 9. Asia Pacific Immunohistochemistry Market, by Application, 2024 & 2034 (USD Million)
- Figure 10. Market by End Use
- Figure 11. Asia Pacific Immunohistochemistry Market, by End Use, 2024 & 2034 (USD Million)
